A PYMNTS Company

UK CMA Accepts CVS’s Offer To Sell The Vet, Ending Probe

By  |  June 28, 2022

The UK Competition & Markets Authority on Monday said it will not progress a probe into CVS’s purchase of Quality Pet Care after the London-listed firm agreed to offload the business in question, in response to competition concerns raised by the CMA.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    In August 2021, Norfolk-based veterinary services firm CVS announced its acquisition of Quality Pet Care, which trades as The Vet, for GBP20.4 million. 

    However, in September, the CMA opened an investigation into the deal, and in February had judged that the acquisition would reduce competition in Bristol, Nottingham, Portsmouth, Southampton and Warrington. It said it would refer the deal for an in-depth investigation unless CVS offered acceptable remedies for the regulator’s concerns.

    In response, CVS offered to divest the entire The Vet business – a solution the CMA on Monday said it had accepted.

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.